WO2003048393A1 - Mixture of two partially denaturating agents for the preparation of pcr buffer solutions - Google Patents

Mixture of two partially denaturating agents for the preparation of pcr buffer solutions Download PDF

Info

Publication number
WO2003048393A1
WO2003048393A1 PCT/IT2001/000611 IT0100611W WO03048393A1 WO 2003048393 A1 WO2003048393 A1 WO 2003048393A1 IT 0100611 W IT0100611 W IT 0100611W WO 03048393 A1 WO03048393 A1 WO 03048393A1
Authority
WO
WIPO (PCT)
Prior art keywords
dmso
buffer solutions
dna
pcr buffer
mixture
Prior art date
Application number
PCT/IT2001/000611
Other languages
French (fr)
Inventor
Vincenzo Nigro
Original Assignee
Bio3 Research Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio3 Research Srl filed Critical Bio3 Research Srl
Priority to PCT/IT2001/000611 priority Critical patent/WO2003048393A1/en
Priority to AU2002217428A priority patent/AU2002217428A1/en
Publication of WO2003048393A1 publication Critical patent/WO2003048393A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Definitions

  • the invention concerns DNA amplification techniques and more particularly the use, in buffer solutions for the polymerase chain reaction (PCR) , of a new mixture of two partially 5 denaturating agents: glycerol and dimetyl sulfoxide (DMSO) . These two agents are able to facilitate DNA denaturation and to minimise, at the same time, the disadvantages related to the use of denaturating agents in PCR buffer 10 solutions.
  • PCR polymerase chain reaction
  • the PCR process comprises three subsequent steps, which are repeated at every single denaturation cycle:
  • DNA polymerase the enzyme responsible for DNA replication
  • the first denaturation step is surely the main reaction and without it the amplification cycle can not proceed.
  • the double elix of DNA loses its primary structure due to hydrogen bounds between nucleotides and hydrophobic interactions between stacked basis and it loses the secondary structures due to close complementary sequences which, within the same molecule, form loops or crosses.
  • DNA denaturation is induced by temperature increasing, by using chemical agents which destabilised the double elix structure or by using extreme pH conditions that gives to nucleotides a net charge and enhance denaturation .
  • formamides The best known and common denaturating agents are formamides, non ionic detergents and dimetylsulfoxide (DMSO) . These compounds have many disadvantages, for example: formamides damages polymerase physical -chemical characteristics; non ionic detergents enhance aspecific amplification rate.
  • DMSO dimetylsulfoxide
  • DMSO causes DNA breaking and polymerase inactivation, on the other hand, it drastically reduces the formation of secondary structures that stop polymerase progression during replication, and furthermore it can induce CG- rich regions denaturation and can improve annealing specificity of the primer-template complex creating more strict reaction conditions, ensuring the bound between each primer and the corresponding DNA sequence .
  • the present invention overcomes the problems related to the use of denaturating agents, like DMSO, in the preparation of PCR buffer solution, providing a new mixture for the preparation of PCR buffer solutions able to reduce DMSO rate and containing compounds enabling the denaturation to be executed at a lower temperature, it can stabilises DNA polymerase and it reduces the risk of incorrect annealing.
  • denaturating agents like DMSO
  • Glycerol a) It's a co-solvent that allows the denaturation reaction to be carried out at lower temperatures. b) It stabilises DNA polimerase c) It reduces false-priming that occurs when primers bound to sequence different from the one to be amplified. This characteristic is very important in multiplex PCR when a large number of primers must bound each to a precise template sequence.
  • DMSO a) It helps DNA denaturation especially of GC- rich regions; b) It improves specificity pairing between primers and templates.
  • DMSO in low concentrations does not damage DNA polymerase (which is quite expensive) enabling the use of lower amounts of the enzyme; it offers an high rate of amplification trough regions of the DNA molecule having different danaturation profiles, and it renders the entire process cheaper; it further avoids the formation of intrachain bounds that stop polymerase progression during replication; it permits the use of a concentration of DMSO which is lower than the one commonly used in buffer solutions in the state of the art, avoiding damages of the DNA molecule to be amplified and the risk of enzymes inactivation; it reduces dangerous false-priming between primers and templates, useful particularly in long PCR when the sequences to be amplified have a length up to 18.000 bais pairs; it allows to have a good DNA polymerase processivity even after long periods of exposure to high temperatures and/or the same denaturating agents .
  • Figure 1 compares the results obtained from a PCR in presence of a buffer solution containing only glycerol at different concentration with those obtained from a PCR in presence of a buffer solution containing glycerol in a concentration of 1% together with DMSO at different concentrations.
  • Axis of ordinates represent band intensity of an electrophoresis test of amplified samples, the minimum amplified quantity is normalised at value 1.
  • the mixture, object of the present invention is characterised in containing a very low amount of DMSO.
  • the mixture, in the final concentration used for the amplification reaction is as follows: DMSO from 0.8 to 1.5 % GLYCEROL from 7 to 9 %
  • the mixture, object of the present invention is characterised in having the following composition in the final concentration used for the amplification reaction:
  • PCR buffer solutions containing the mixture of partially denaturating agents, object of the present invention are extremely suitable for GC- rich regions PCR, for multiplex PCR and for Long PCR.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The object of the invention is a new mixture of two partially denaturating agents to be used for the preparation of PCR buffer solutions in order to enhance the rate of the DNA denaturation reactions.

Description

MIXTURE OF TWO PARTIALLY DENATURATING AGENTS FOR THE PREPARATION OF PCR BUFFER SOLUTIONS
The invention concerns DNA amplification techniques and more particularly the use, in buffer solutions for the polymerase chain reaction (PCR) , of a new mixture of two partially 5 denaturating agents: glycerol and dimetyl sulfoxide (DMSO) . These two agents are able to facilitate DNA denaturation and to minimise, at the same time, the disadvantages related to the use of denaturating agents in PCR buffer 10 solutions.
As already known, PCR (polymerase chain reaction) is surely the technique that has completely changed the molecular biology permitting the fast, cheap and efficient
15 synthesis of DNA.
The PCR process comprises three subsequent steps, which are repeated at every single denaturation cycle:
1. During the first reaction (denaturation) the 20 double elix of DNA opens to the two complementary single DNA strands.
2. In the second step, called annealing reaction, short sequences of single DNA strand of 20 bais pairs, called primers, because of DNA
25 complementarity, bound the sequences adjacent to each end of the called target region. 3. In the last step, called polymerisation reaction, DNA polymerase (the enzyme responsible for DNA replication) synthesised from the 3' -OH end a single DNA strand that is complementary to the sequence to be amplified.
The first denaturation step is surely the main reaction and without it the amplification cycle can not proceed. During this reaction, the double elix of DNA loses its primary structure due to hydrogen bounds between nucleotides and hydrophobic interactions between stacked basis and it loses the secondary structures due to close complementary sequences which, within the same molecule, form loops or crosses. In the common laboratory practice, DNA denaturation is induced by temperature increasing, by using chemical agents which destabilised the double elix structure or by using extreme pH conditions that gives to nucleotides a net charge and enhance denaturation .
The best known and common denaturating agents are formamides, non ionic detergents and dimetylsulfoxide (DMSO) . These compounds have many disadvantages, for example: formamides damages polymerase physical -chemical characteristics; non ionic detergents enhance aspecific amplification rate.
DMSO causes DNA breaking and polymerase inactivation, on the other hand, it drastically reduces the formation of secondary structures that stop polymerase progression during replication, and furthermore it can induce CG- rich regions denaturation and can improve annealing specificity of the primer-template complex creating more strict reaction conditions, ensuring the bound between each primer and the corresponding DNA sequence .
Nowadays, commercially available buffer solutions, contain DMSO in a rate higher than 3%, usually between 3% and 10%, and do not contains compounds capable to minimise DMSO negative effects on DNA sequence preventing and on polymerase activity.
The present invention overcomes the problems related to the use of denaturating agents, like DMSO, in the preparation of PCR buffer solution, providing a new mixture for the preparation of PCR buffer solutions able to reduce DMSO rate and containing compounds enabling the denaturation to be executed at a lower temperature, it can stabilises DNA polymerase and it reduces the risk of incorrect annealing.
This is obtained using, according to the present invention, a new mixture of DMSO and Glycerol where each component shows the following features : Glycerol : a) It's a co-solvent that allows the denaturation reaction to be carried out at lower temperatures. b) It stabilises DNA polimerase c) It reduces false-priming that occurs when primers bound to sequence different from the one to be amplified. This characteristic is very important in multiplex PCR when a large number of primers must bound each to a precise template sequence. DMSO: a) It helps DNA denaturation especially of GC- rich regions; b) It improves specificity pairing between primers and templates.
At the same time, experimental results, have underlined that the two components of the mixtures show, out of their own characteristics, an high synergic activity, which gives to the containing buffer solutions the unique features as follows:
DMSO in low concentrations, thanks to the combination with glycerol, does not damage DNA polymerase (which is quite expensive) enabling the use of lower amounts of the enzyme; it offers an high rate of amplification trough regions of the DNA molecule having different danaturation profiles, and it renders the entire process cheaper; it further avoids the formation of intrachain bounds that stop polymerase progression during replication; it permits the use of a concentration of DMSO which is lower than the one commonly used in buffer solutions in the state of the art, avoiding damages of the DNA molecule to be amplified and the risk of enzymes inactivation; it reduces dangerous false-priming between primers and templates, useful particularly in long PCR when the sequences to be amplified have a length up to 18.000 bais pairs; it allows to have a good DNA polymerase processivity even after long periods of exposure to high temperatures and/or the same denaturating agents .
Figure 1 compares the results obtained from a PCR in presence of a buffer solution containing only glycerol at different concentration with those obtained from a PCR in presence of a buffer solution containing glycerol in a concentration of 1% together with DMSO at different concentrations. Axis of ordinates represent band intensity of an electrophoresis test of amplified samples, the minimum amplified quantity is normalised at value 1.
Data represented in the graphic are listed in the following table:
% glycerol glycerol glycerol + 1% DMSO
0% 2,5 3,5
3% 3 5
6% 7 9 8% 7 11
10% 7 8,5
12% 3 4
15% 1 1
The mixture, object of the present invention is characterised in containing a very low amount of DMSO.
The mixture, in the final concentration used for the amplification reaction is as follows: DMSO from 0.8 to 1.5 % GLYCEROL from 7 to 9 % In a preferred embodiment the mixture, object of the present invention, is characterised in having the following composition in the final concentration used for the amplification reaction:
DMSO 1 %
GLYCEROL 8 % In conclusion, the use of the new mixture of DMSO and glycerol, for the preparation of PCR buffer solutions allows the optimisation of the amplification reaction rate because the combination between glycerol and DMSO enables the use of amounts of DMSO lower than those known up to now, and this fact consequently reduces all the inhibiting effects on polymerase and the risks of damaging the DNA molecules to be syntetised. PCR buffer solutions containing the mixture of partially denaturating agents, object of the present invention, are extremely suitable for GC- rich regions PCR, for multiplex PCR and for Long PCR.

Claims

1. Use of DMSO and glycerol for the preparation of PCR buffer solutions.
2. PCR buffer solution characterised in that, it comprises the following components in a final concentration used in the amplification reaction: DMSO from 0.8 to 1.5 %
GLYCEROL from 7 to 9 %
3. PCR buffer solution according to claim 2 characterised in that DMSO is an a concentration of 1% and glycerol is in a concentration of 8%.
PCT/IT2001/000611 2001-12-04 2001-12-04 Mixture of two partially denaturating agents for the preparation of pcr buffer solutions WO2003048393A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IT2001/000611 WO2003048393A1 (en) 2001-12-04 2001-12-04 Mixture of two partially denaturating agents for the preparation of pcr buffer solutions
AU2002217428A AU2002217428A1 (en) 2001-12-04 2001-12-04 Mixture of two partially denaturating agents for the preparation of pcr buffer solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2001/000611 WO2003048393A1 (en) 2001-12-04 2001-12-04 Mixture of two partially denaturating agents for the preparation of pcr buffer solutions

Publications (1)

Publication Number Publication Date
WO2003048393A1 true WO2003048393A1 (en) 2003-06-12

Family

ID=11133761

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2001/000611 WO2003048393A1 (en) 2001-12-04 2001-12-04 Mixture of two partially denaturating agents for the preparation of pcr buffer solutions

Country Status (2)

Country Link
AU (1) AU2002217428A1 (en)
WO (1) WO2003048393A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912151A1 (en) * 2007-02-05 2008-08-08 Arkema France Crystallization point lowering additive for dimethyl sulfoxide, e.g. during use as paint stripper or surface cleaner, comprises diol and/or triol, especially glycerol
US10858696B2 (en) 2014-06-02 2020-12-08 Illumina Cambridge Limited Methods of reducing density-dependent GC bias in amplification
US11591643B2 (en) 2016-06-30 2023-02-28 Lumiradx Uk Ltd. In or relating to uncleic acid amplification processes
US11655496B2 (en) 2018-01-04 2023-05-23 Lumiradx Uk Ltd. Amplification of nucleic acids

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0669401A2 (en) * 1994-02-25 1995-08-30 F. Hoffmann-La Roche Ag Amplification of long nucleic acid sequences by PCR

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0669401A2 (en) * 1994-02-25 1995-08-30 F. Hoffmann-La Roche Ag Amplification of long nucleic acid sequences by PCR

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHENG S ET AL: "EFFECTIVE AMPLIFICATION OF LONG TARGETS FROM CLONED INSERTS AND HUMAN GENOMIC DNA", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 91, no. 12, June 1994 (1994-06-01), pages 5695 - 5699, XP000982285, ISSN: 0027-8424 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912151A1 (en) * 2007-02-05 2008-08-08 Arkema France Crystallization point lowering additive for dimethyl sulfoxide, e.g. during use as paint stripper or surface cleaner, comprises diol and/or triol, especially glycerol
WO2008107611A3 (en) * 2007-02-05 2008-11-06 Arkema France Dimethylsulfoxide formulation in mixture with additive for lowering the crystallization point of same, and applications of said mixture
US7959767B2 (en) 2007-02-05 2011-06-14 Arkema France Dimethyl sulfoxide formulation in mixture with additive for lowering the crystallization point of same, and applications of said mixture
US8741826B2 (en) 2007-02-05 2014-06-03 Arkema France Dimethylsulfoxide formulation in mixture with additive for lowering the crystallization point of same, and applications of said mixture
EP3795648A1 (en) 2007-02-05 2021-03-24 Gaylord Chemical Company LLC Formulation of dimethyl sulfoxide in mixture with an additive capable of reducing the crystallisation point of the latter, and uses of said mixture
US10858696B2 (en) 2014-06-02 2020-12-08 Illumina Cambridge Limited Methods of reducing density-dependent GC bias in amplification
US11591643B2 (en) 2016-06-30 2023-02-28 Lumiradx Uk Ltd. In or relating to uncleic acid amplification processes
US11655496B2 (en) 2018-01-04 2023-05-23 Lumiradx Uk Ltd. Amplification of nucleic acids

Also Published As

Publication number Publication date
AU2002217428A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
EP3298170B1 (en) Methods for generating circular dna from circular rna
AU2012307282B2 (en) Nucleic acid transcription method
JP3867926B2 (en) Nucleic acid amplification method
EP3256584B1 (en) Method and compositions for reducing non-specific amplification products
JP5702148B2 (en) Reduced inhibition of 1-step RT-PCR
WO2017141067A1 (en) Method of eliminating background amplification of nucleic acid targets
US20170362623A1 (en) Amplification of nucleic acids
WO2010026933A1 (en) Composition for detection of rna
CN110506114B (en) PCR primer pair and application thereof
WO2003048393A1 (en) Mixture of two partially denaturating agents for the preparation of pcr buffer solutions
JP7106461B2 (en) Thermostable polymerase inhibitor compositions and methods
JPWO2002036822A1 (en) Nucleic acid base sequencing method
Asif et al. PCR Optimization for Beginners: A Step by Step Guide
AU2016231995A1 (en) PCR method
Best et al. Molecular pathology methods
Panelli et al. Ligation overcomes terminal underrepresentation in multiple displacement amplification of linear DNA
WO2017088750A1 (en) Method and kit for deviation amplification of target nucleic acid sequence in sample
EP4010493A1 (en) Methods for the multiplexed isothermal amplification of nucleic acid sequences
JP7191115B2 (en) Method for amplification of nucleic acids by endonuclease-mediated migration equilibrium (EM-SEq)
JP4104285B2 (en) DNA amplification method and kit thereof
US20140329702A1 (en) Method of amplifying a nucleic acid
US20230340462A1 (en) Method for producing dna molecules having an adaptor sequence added thereto, and use thereof
JP2022170729A (en) Novel method for preparing gene libraries
CN112359031A (en) Hot-start DNA polymerase and preparation method and application thereof
JP2005102502A (en) Method for amplifying single-stranded nucleic acid fragment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP